Evidence map›Paper›PMID 41158917›Full record

ArticleCureus2025

Leser-Trélat Sign as an Initial Manifestation of Synchronous Prostate and Bladder Cancer.

Alper Okur, Kadir Can Şahin, Zehra Sahin, Mehmet Hamza Gultekin, Bulent Onal

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alper OkurUrology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, TUR.
Kadir Can ŞahinUrology, Istanbul Bayrampasa State Hospital, Istanbul, TUR.
Zehra SahinMedical Pathology, Istanbul Gaziosmanpasa Training and Research Hospital, Istanbul, TUR.
Mehmet Hamza GultekinUrology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, TUR.
Bulent OnalUrology, Cerrahpasa Faculty of Medicine, Istanbul University - Cerrahpasa, Istanbul, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Leser-Trélat sign, marked by the sudden onset and rapid proliferation of seborrheic keratoses, is a rare paraneoplastic phenomenon associated with internal malignancies. This report presents a case of a 75-year-old male with a history of hypertension and diabetes who presented with an elevated PSA level and was subsequently diagnosed with synchronous prostate adenocarcinoma and high-grade invasive urothelial carcinoma. Prior to the oncologic diagnoses, the patient exhibited cutaneous lesions consistent with the Leser-Trélat sign, which raised clinical suspicion for an underlying malignancy. The patient's treatment course comprised transurethral resection of the bladder tumor, complete intravesical Bacillus Calmette-Guérin therapy, radical prostatectomy, and subsequent combined androgen deprivation therapy with salvage radiotherapy due to persistent postoperative PSA elevation. The stabilization of the patient's dermatologic manifestations following oncologic treatment supports the hypothesis of a paraneoplastic origin. The Leser-Trélat sign, while infrequent and debated, may serve as an early indicator of malignancy, particularly when observed with atypical seborrheic keratosis distribution. Although the pathogenesis remains incompletely understood, molecular associations such as FGFR3 mutations have been implicated. The co-occurrence of this sign with synchronous genitourinary malignancies underscores the importance of a multidisciplinary approach to diagnosis and management. Further investigation is warranted to elucidate the precise underlying mechanisms of this rare phenomenon and its potential role in oncologic detection.

Indexed as

leser-trélat signparaneoplastic skin diseaseprostate adenocarcinomaseborrheic keratosesurothelial bladder cancer

Identifiers

PMID41158917
PMCPMC12555779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.